Bruce Cree
George A. Zimmermann Endowed Chair in Neurology · University of California (San Francisco) School of Medicine
Credentials: · · · ·
History
- 1998–2002
Neurology
Research
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature · 2011 · 2,133 citations
Risk alleles for multiple sclerosis identified by a genomewide study
New England Journal of Medicine · 2007 · 1,326 citations
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Nature Genetics · 2013 · 1,106 citations

97 papers

47 papers

45 papers · 1 as a resident

33 papers

30 papers
- SZ
30 papers

25 papers

22 papers
Grants
- 2005–2010
Correlating Multiple Sclerosis Phenotypes with Genotypes
National Institute of Neurological Disorders and Stroke · K23
Contact PI · $807K · University of California, San Francisco
Clinical trials
- 2024–2027
Principal investigator · Active not recruiting · Phase 1
Bruce Cree
- 2020–2027
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
Principal investigator · Active not recruiting · Phase 4
University of California, San Francisco
- 2016–2020
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
Principal investigator · Terminated · Phase 3
MedDay Pharmaceuticals SA
- 2004–2010
Safety and Tolerability of Rituximab in Neuromyelitis Optica
Principal investigator · Completed · Phase 1
University of California, San Francisco


